Methods and compositions for ati digestion
AssigneeGlutagen Pty Ltd
InventorsMichelle Lisa COLGRAVE, Angéla JUHÁSZ, Gregory John TANNER, Ezequiel PENA
Life of this patent
Estimating the term…
Abstract
The present invention is generally related to methods of digesting α-amylase/trypsin inhibitors (ATI), and to the treatment and/or prophylaxis of an α-amylase/trypsin inhibitor (ATI) mediated conditions.
Claims36
A method for digesting at least one alpha amylase trypsin inhibitor (ATI), the method comprising contacting an ATI with an effective dose of a composition comprising a proteolytic preparation comprising one or more Carica papaya endopeptidases.
A method for digesting at least one alpha amylase trypsin inhibitor (ATI) in an ATI-containing foodstuff, the method comprises contacting the ATI-containing foodstuff with an effective dose of a composition comprising a proteolytic preparation comprising one or more Carica papaya endopeptidases.
(canceled)
(canceled)
(canceled)
(canceled)
A method for the treatment and/or prevention of an alpha-amylase/trypsin inhibitor (ATI) mediated condition, comprising administering to a subject in need thereof an effective amount of a composition comprising a proteolytic preparation comprising one or more Carica papaya endopeptidases, preferably wherein the condition is a wheat alpha-amylase/trypsin inhibitor (ATI) mediated condition.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.